美諾華(603538.SH):阿託伐他汀鈣原料藥獲得歐洲CEP證書
格隆匯9月19日丨美諾華(603538.SH)公佈,公司收到歐洲藥品質量管理局(簡稱“EDQM”)簽發的關於阿託伐他汀鈣(原料藥)的歐洲CEP證書(歐洲藥典適用性證書),阿託伐他汀鈣為他汀類血脂調節藥,主要作用部位在肝臟,可減少膽固醇的合成,增加低密度脂蛋白受體合成,使血膽固醇和低密度脂蛋白膽固醇水平降低,中度降低血清甘油三酯水平和增高血高密度脂蛋白水平。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.